KALC-IC 2024

Transportation

By Subway

Line 2Line 8
Jamsil Station

Exit 3
Walk : 3 minutes
By Bus
In front of LOTTE Department Store Jamsil
- Blue Bus : 301, 341, 351, 360, 362
- Green Bus : 2415, 3217, 3313, 3314, 3315, 3317, 3411, 3412, 3414, 4318, 4319

Incheon International Airport is the main part of arrival for most flights from outside Korea.
Located approximately 1 hour from downtown Seoul,
there are a number of convenient ways to get to the city from the airport.

Airport Bus

Airport buses travel to all major areas of Seoul. Tickets are KRW 12,000 to 18,000 and the travel time is approximately 60 to 80 minutes, depending on traffic and the destination.
Tickets can be purchased at designated ticket outside the passenger terminal, or fare can be paid in cash, T-money, or credit card (at Incheon Airport).

Incheon Airport Terminal 1 Schedule


Hour	01	02	03	04	05	06	07	08	09	10	11	12
Minute	-	-	-	-	20	00 30	00 30	00 33	13 40	15 30	25	00 30
Hour	13	14	15	16	17	18	19	20	21	22	23	24
Minute	00 30	00 30	02 25	00 30	05 38	10 40	15 45	20 48	20 45	12 32 52	15	-

※ Please be advised that actual times may vary depending on traffic conditions.

Incheon Airport Terminal 2 Schedule


Hour	01	02	03	04	05	06	07	08	09	10	11	12
Minute	-	-	-	-	00 40	10 40	10 40	13 53	20 55	30	05 40	10 40
Hour	13	14	15	16	17	18	19	20	21	22	23	24
Minute	10 40	10 42	05 42	10 45	18 50	20 55	25	00 28	00 25 52	12 32 55	-	-

※ Please be advised that actual times may vary depending on traffic conditions.

Jamsil Lotte World Hotel Schedule


Hour	01	02	03	04	05	06	07	08	09	10	11	12
Minute	-	-	-	05 30 55	20 45	10 35	05 45	25	10 50	30	00 30	00 30
Hour	13	14	15	16	17	18	19	20	21	22	23	24
Minute	05 40	15 45	15 45	15 45	15 45	15 45	15	-	-	-	-	-

※ Please be advised that actual times may vary depending on traffic conditions.

Abstract No.	Presentation Time	Abstract Title	Presenter Name	Affiliation	Country
A-0186	14:45-14:55	Spatial transcriptomics reveals spatially diverse cancer-associated fibroblasts in lung squamous cell carcinoma linked to tumor progression	Kwon Joong Na	Seoul National University	Korea
A-0184	14:55-15:05	Single-cell RNA sequencing revealed that changes in monocytes are involved in the prognosis of durvalumab consolidation therapy following chemoradiotherapy	Duk Ki Kim	Chungnam National University	Korea
A-0105	15:05-15:15	Landscape of tumor heterogeneity and tumor mutational burden (TMB) in non-small cell lung cancer (NSCLC)	Jong Yeob Kim	Feinberg School of Medicine, Northwestern University	USA
A-0127	15:15-15:25	Induction of malignant transformation in human bronchial epithelial cells and lung organoids by chronic exposure to whole cigarette smoke extract	Chaeuk Chung	Chungnam National University	Korea
A-0057	15:25-15:35	Identification of GREM-1 and GAS6 as specific biomarkers for cancer-associated fibroblasts derived from patients with non-small cell lung cancer	Bo-Guen Kim	Kangbuk Samsung Medical Center	Korea
A-0042	15:35-15:45	Spatially defined co-culture model of non-small cell lung cancer organoids and cancer-associated fibroblasts to investigate phenotypic heterogeneity	Cheol-Kyu Park	Chonnam National University	Korea

Abstract No.	Presentation Time	Abstract Title	Presenter Name	Affiliation	Country
A-0226	09:10-09:20	Perioperative outcomes of neoadjuvant chemoimmunotherapy followed by surgery in stage II-III NSCLC: A real-world study	Junghee Lee	Samsung Medical Center	Korea
A-0214	09:20-09:30	Preliminary analysis of lazertinib consolidation therapy in patients with locally advanced, unresectable, EGFR mutated NSCLC following chemoradiation therapy: PLATINUM trial	Sung Yong Lee	Korea University	Korea
A-0204	09:30-09:40	What Is the Optimal Dose and Fractionation Schedule for Inoperable Node-Negative Large (>5 cm) Non-Small Cell Lung Cancer?	Ye Jin Yoo	Asan Medical Center	Korea
A-0108	09:40-09:50	Double lung transplantation in patients with metastatic lung-limited non-small cell lung carcinoma (NSCLC): A case series	Young Chae	Northwestern University Feinberg School of Medicine	USA
A-0069	09:50-10:00	Normal brain-sparing radiotherapy versus whole brain radiotherapy for multiple brain metastasis from non-small cell lung cancer	Sangjoon Park	Severance Hospital	Korea
A-0046	10:00-10:10	Refining patient selection for prophylactic cranial irradiation in limited-stage small-cell lung cancer: Insights from a Korean multi-institutional cohort study	Hye In Lee	Asan Medical Center	Korea

Abstract No.	Presentation Time	Abstract Title	Presenter Name	Affiliation	Country
A-0080	10:25-10:35	Real-world insights: Treatment patterns and overall survival in patients with small-cell lung cancer in South Korea a single center experience	Sehhoon Park	Samsung Medical Center, Sungkyunkwan University School of Medicine	Korea
A-0196	10:35-10:45	AI-powered pathologic response evaluation of post-neoadjuvant chemoimmunotherapy in NSCLC patients	Kwon Joong Na	Seoul National University	Korea
A-0167	10:45-10:55	Enhanced thrombopoiesis supplies PD-L1 to circulating immune cells via the generation of PD-L1-Expressing platelets in lung cancer patients	Jae Ho Cho	Chonnam National University Medical School	Korea
A-0230	10:55-11:05	Chemotherapy plus immune checkpoint inhibitors in non-small cell lung cancer with actionable gene alterations other than EGFR, ALK, and ROS1	Ji Eun Shin	The Catholic University of Korea St. Vincent's Hospital	Korea
A-0131	11:05-11:15	Sequential hypofractionated radiotherapy followed by anti-PD-L1 atezolizumab for recurrent or refractory small cell lung cancer	Yang-Gun Suh	National Cancer Center	Korea
A-0035	11:15-11:25	Imaging trajectory of transformation into small-cell carcinomas from lung adenocarcinomas undergoing TKI treatment: radiomic prediction	Jihwan Choi	Samsung Medical Center	Korea